Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

677.56 -15.12 (-2.18%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

March 18, 2025

From Medpace Holdings, Inc.

Via Business Wire

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

March 18, 2025

Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.

Via StockStory

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 11, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...

Via StockStory

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

March 05, 2025

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today ↗

October 22, 2024

Via Benzinga

2 Reasons to Watch MEDP and 1 to Stay Cautious

March 03, 2025

Medpace has been treading water for the past six months, recording a small loss of 4.4% while holding steady at $334.43. The stock also fell short of the S&P 500’s 7.6% gain during that period.

Via StockStory

Topics Stocks

Why Medpace (MEDP) Shares Are Trading Lower Today

February 11, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after the company reported weak fourth-quarter results: Medpace's full-year revenue, EPS, and...

Via StockStory

Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 11, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

February 10, 2025

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Medpace Stock Falls On Q4 Earnings: The Details ↗

February 10, 2025

Medpace Holdings Inc (NASDAQ:MEDP) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.

Via Benzinga

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

February 10, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On the other hand, the company’s...

Via StockStory

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results

February 10, 2025

From Medpace Holdings, Inc.

Via Business Wire

Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

February 09, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours. Here’s what to expect.

Via StockStory

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

January 02, 2025

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For February 10, 2025 ↗

February 10, 2025

Via Benzinga

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

December 16, 2024

Via ACCESSWIRE

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Medpace Holdings Inc For Securities Law Violations

December 15, 2024

Via ACCESSWIRE

Medpace Holdings, Inc. Is Being Investigated For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

December 14, 2024

Via ACCESSWIRE

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medpace Holdings Inc For Securities Law Violations

December 13, 2024

Via ACCESSWIRE

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

December 12, 2024

Via ACCESSWIRE

10 Health Care Stocks Whale Activity In Today's Session ↗

December 05, 2024

Via Benzinga

MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm

November 12, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

November 08, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

October 31, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Aviat, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm

October 29, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm

October 23, 2024

From The Schall Law Firm

Via Business Wire

This McDonald's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

October 23, 2024

Via Benzinga

NASDAQ: MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

October 22, 2024

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Why Is Medpace Stock Diving On Tuesday? ↗

October 22, 2024

Medpace Holdings reports Q3 results with revenue of $533.3M, below consensus. Backlog and EBITDA increased. Medspace lowered its FY24 revenue forecast.

Via Benzinga

How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025 ↗

October 22, 2024

The contract research organization missed bookings expectations, but didn't offer into any insight into the impact for 2025.

Via Investor's Business Daily

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.